TFF Pharmaceuticals Inc TFFP.OQ TFFP.O is expected to show a fall in quarterly revenue when it reports results on November 18 (estimated) for the period ending September 30 2024
The Austin Texas-based company is expected to report a 14.9% decrease in revenue to $200 thousand from $235 thousand a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for TFF Pharmaceuticals Inc is for a loss of 81 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for TFF Pharmaceuticals Inc is $30.00, above its last closing price of $1.60.
This summary was machine generated November 15 at 21:04 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments